Saturday 26 May 2018
Contact US    |    Archive
Reuters
1 months ago

UPDATE 3-Amgen expects strong demand for new migraine prevention drug

April 24 (Reuters) - Amgen Inc on Tuesday reported a higher first-quarter profit, as sales rose 3 percent - a trend it expects to accelerate as it launches new drugs like migraine treatment Aimovig, likely to get U.S. approval next month.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

UPDATE

 | 

Amgen

 | 

expects

 | 

strong

 | 

demand

 | 

for

 | 

new

 | 

migraine

 | 

prevention

 | 

drug

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
USA